Vanderbilt University Medical Center: Diagnostic Biomarker For Bone Disorder
September 28, 2022
September 28, 2022
NASHVILLE, Tennessee, Sept. 28 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
Hypophosphatasia (HPP) -- a rare genetic disorder that impacts the mineralization of bones and teeth -- has a wide spectrum of disease presentation and is challenging to diagnose.
Kathryn Dahir, MD, and colleagues evaluated urine phosphoethanolamine (PEA) as a marker for HPP diagnosis and treatment monitoring. They collected data from the records of 78 adults who . . .
Hypophosphatasia (HPP) -- a rare genetic disorder that impacts the mineralization of bones and teeth -- has a wide spectrum of disease presentation and is challenging to diagnose.
Kathryn Dahir, MD, and colleagues evaluated urine phosphoethanolamine (PEA) as a marker for HPP diagnosis and treatment monitoring. They collected data from the records of 78 adults who . . .